Funding Available for WAS Research for 2021-2023
The Wiskott-Aldrich Foundation (WAF) is announcing a call for research proposals to be granted in 2021-2023. WAF will grant seed money funding for a total of $100,000 for one proposal or for two proposals for $50,000 each.
Areas of Interest:
- New and innovative curative treatment approaches for X‐linked thrombocytopenia (XLT)/Wiskott‐Aldrich Syndrome (WAS) with reduced mortality and morbidity.
- Innovative methods to better existent curative treatments leading to less mortality, morbidity, and or improved correction of the disease.
Application Deadline: September 30, 2020
Letter of Intent Form